Pulse Biosciences (PLSE) Gains from Investment Securities (2015 - 2025)

Pulse Biosciences' quarterly Gains from Investment Securities came in at -$28000.0 in Q4 2025, down 190.32% year-on-year from $31000.0 in Q4 2024, and down 102.33% quarter-over-quarter from $1.2 million in Q3 2025.

Pulse Biosciences has reported Gains from Investment Securities for 11 years, with the latest figure at -$28000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 190.32% year-over-year to -$28000.0; the trailing twelve-month figure through Dec 2025 stood at -$229000.0 (down 8.53% YoY), and the FY2025 full-year result was $2.3 million, down 79.01% from the prior year.
  • Gains from Investment Securities for Q4 2025 stood at -$28000.0, down from $1.2 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $9.5 million in Q4 2023, with the low at -$232000.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $1.5 million, with a median of $527886.0 recorded in 2023.
  • Year-over-year, Gains from Investment Securities sank 2220.0% in 2021 and surged 2138.96% in 2022.
  • Tracing PLSE's Gains from Investment Securities over 5 years: stood at -$232000.0 in 2021, then surged by 2138.96% to $4.7 million in 2022, then surged by 100.11% to $9.5 million in 2023, then plunged by 99.67% to $31000.0 in 2024, then plunged by 190.32% to -$28000.0 in 2025.
  • The last three Gains from Investment Securities figures came in at -$28000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pulse Biosciences 1.72 Bn 1.72 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -28,000.00
Dec 31, 2025 -28,000.00
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 442,678.00
Mar 31, 2025 442,678.00
Dec 31, 2024 31,000.00
Dec 31, 2024 31,000.00
Sep 30, 2024 855,000.00
Sep 30, 2024 855,000.00
Jun 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Dec 31, 2023 9.47 Mn
Dec 31, 2023 9.47 Mn
Sep 30, 2023 527,886.00
Sep 30, 2023 527,886.00
Jun 30, 2023 1.74 Mn
Jun 30, 2023 1.74 Mn
Mar 31, 2023 68,894.00
Mar 31, 2023 68,894.00
Dec 31, 2022 4.73 Mn
Dec 31, 2022 4.73 Mn
Sep 30, 2022 564,558.00
Sep 30, 2022 564,558.00
Jun 30, 2022 277,018.00
Jun 30, 2022 277,018.00
Mar 31, 2022 203,354.00
Mar 31, 2022 203,354.00
Dec 31, 2021 -232,000.00
Dec 31, 2021 -232,000.00
Sep 30, 2021 111,279.00
Sep 30, 2021 111,279.00
Jun 30, 2021 5.83 Mn
Jun 30, 2021 5.83 Mn
Mar 31, 2021 68,654.00
Mar 31, 2021 68,654.00
Dec 31, 2020 -10,000.00
Dec 31, 2020 -10,000.00
Sep 30, 2020 5.21 Mn
Sep 30, 2020 5.21 Mn
Jun 30, 2020 1.82 Mn
Jun 30, 2020 1.82 Mn
Mar 31, 2020 13,000.00
Mar 31, 2020 13,000.00
Dec 31, 2019 604,000.00
Dec 31, 2019 604,000.00
Sep 30, 2019 40,582.00
Sep 30, 2019 40,582.00
Jun 30, 2019 1.29 Mn
Jun 30, 2019 1.29 Mn
Mar 31, 2019 2.87 Mn
Mar 31, 2019 2.87 Mn
Dec 31, 2018 -76,000.00
Dec 31, 2018 -76,000.00
Sep 30, 2018 417,000.00
Sep 30, 2018 417,000.00
Jun 30, 2018 69,375.00
Jun 30, 2018 69,375.00
Mar 31, 2018 12,000.00
Mar 31, 2018 12,000.00
Dec 31, 2017 3.70 Mn
Dec 31, 2017 3.70 Mn
Sep 30, 2017 68,800.00
Sep 30, 2017 68,800.00
Jun 30, 2017 160,974.00
Jun 30, 2017 160,974.00
Mar 31, 2017 58,000.00
Mar 31, 2017 58,000.00
Dec 31, 2016 1.23 Mn
Dec 31, 2016 1.23 Mn
Sep 30, 2016 6,000.00
Sep 30, 2016 6,000.00
Jun 30, 2016 6,000.00
Jun 30, 2016 6,000.00
Dec 31, 2015 875,221.00
Dec 31, 2015 875,221.00